healthcare
China mobile healthcare developer gets $50m Series C round
Spring Rain Software, a Chinese mobile healthcare app developer, has raised a $50 million Series C round from new investors China International Capital Corp. (CICC), Rushan Investment Management and Temasek Holdings’ Pavilion Capital.
CITIC PE scraps plans for Biosensors takeover
CITIC Private Equity has abandoned plans for a takeover of Singapore-listed Biosensors International, although it will remain an active investor in the medical device manufacturer.
Walden Riverwood leads $8m Series A for Japan's Atonarp
Walden Riverwood Ventures has led an $8 million Series A round of funding for Atonarp, a Japanese developer of chemical sensors.
Sabre leads $8m round for Indian dermatology specialist
Sabre Partners as led an $8 million Series B round of funding for Vyome Biosciences, an Indian bio-pharmaceutical company that specializes in dermatology.
Qualcomm backs India's Portea Medical
Qualcomm Ventures, the venture investment unit of US chip-maker Qualcomm, has invested in India's Portea Medical, a provider of in-home healthcare services. The financial details of the transaction were not disclosed.
Shares in PE-backed Healthscope climb 5.2% on ASX debut
Shares in Healthscope,the Australian hospital operator backed by TPG Capital and The Carlyle Group, rose 5.2% to A$2.21 at the end its first day of trading yesterday following the largest Australian IPO in four years.
TPG, Carlyle to price Healthscope IPO at upper-end of range - report
TPG Capital and The Carlyle Group are to price shares in Australian hospital chain Healthscope at A$2.10 a share - the upper-end of the target range, generating A$2.25 billion ($2.12 billion).
China's JD Capital launches medical, energy funds
JD Capital has launched three renminbi-denominated funds to invest in the medical and energy sectors.
China M&A funds: Double team
Keen to consolidate their fragmented industries, Chinese companies are partnering up with PE firms to launch M&A funds. But do the GPs have the right skills and are third-party LPs willing to come on board?
Town Health International Medical to invest in Chinese PE fund
Town Health International Medical Group, a Hong Kong-listed dental clinics operator, has contributed RMB15.5 million ($2.5 million) to a PE fund launched by a unit of the Guizhou provincial government.
Partial exit for PE investors as Luye Pharma raises $764m
CDH Investments, CITIC Private Equity, New Horizon Capital and GIC Private have made partial exits from Luye Pharma Group as the Chinese drug maker raised HK$5.91 billion ($764 million) through its Hong Kong IPO.
CITIC Capital leads acquisition of US dental firm
CITIC Capital Partners has acquired US-based dental business DDS LAB for an undisclosed sum. The Chinese PE firm has completed approximately 15 deals in the US but this is its first as lead investor.
JBIC invests $10.5m in India-based Takshasila Hospitals
The government-backed Japan Bank for International Cooperation (JBIC) has invested INR630 million ($10.5 million) in India's Takshasila Hospitals, which operates Sakra World Hospital in Bangalore.
China’s Longmaster acquires IDG's health site 39.net
Longmaster Information & Technology, a Shenzhen-listed software developer, has bought Chinese healthcare portal 39.net for RMB650 million ($105 million), facilitating an exit for IDG Capital Partners.
PE-backed Monash IVF loses momentum after $298m IPO
Shares in Australian in vitro fertilization company Monash IVF Group slipped below the offering price on the second day of trading, following a A$315.9 million ($298 million) IPO that saw Ironbridge Capital exit the majority of its holding.
China menstruation-tracking app Meet You raises $35m
SIG Asia Investment has led a $35 million Series C round of funding for Meet You, a Chinese menstrual health mobile app, with participation from Matrix Partners and China Renaissance K2 Ventures.
Riverside buys Australia orthopedics business
Global mid-market buyout firm The Riverside Company has acquired Global Orthopaedic Technologies (GOT), an Australian orthopaedic implants manufacturer.
CDH, China Grand Pharma buy control of contact lens maker
CDH Investments has teamed up with Hong Kong-listed China Grand Pharmaceutical & Healthcare to acquire a 71.25% stake in contact lens maker Shanghai Weicon Optical for $78.75 million.
PE-owned Luye Pharma seeks up to $764m in HK IPO
Luye Pharma Group - a Chinese drugmaker backed by GIC Private, CDH Investments, CITIC Private Equity and New Horizon Capital - is seeking to raise up to 764 million from a Hong Kong IPO.
TPG, Carlyle favor IPO exit for Australia's Healthscope – report
TPG Capital and The Carlyle Group are reportedly looking to take Healthscope public rather than seek to exit Australia’s second-largest private hospital operator via a trade sale.
Carlyle to acquire Japan's Sunsho Pharmaceutical
The Carlyle Group has agreed to acquire Sunsho Pharmaceutical, a contract manufacturer in the Japan's health and nutrition (H&N) industry. The financial details of the transaction - which will see the PE firm take a 100% stake - were not disclosed.
Milestone leads $35m Series B round for JHL Biotech
Milestone Capital has led a $35 million Series B round of investment for JHL Biotech, a Taiwan-based biopharmaceutical company.
OPIC backs Quadria healthcare fund, CX India mezzanine vehicle
The Overseas Private Investment Corporation (OPIC) has made commitments to Quadria Capital South and Southeast Asia-focused healthcare fund and CX Partners’ India mezzanine fund.
Japan's Meiji acquires India drug maker, Temasek exits
Japanese conglomerate Meiji Holdings has acquired Medreich, an Indian pharmaceutical company backed by Singapore sovereign wealth fund Temasek Holdings, for $290 million via its subsidiary Meiji Seika Pharma.